eISSN: 1643-3750

Logo




Get your full text copy in PDF

Possible biological indicators of the response to recombinant Tumor Necrosis Factor alpha in patients with advanced neoplasms

MaƂgorzata Muc-Wierzgon, Janusz Wierzgon, Katarzyna Madej, Marek Baranowski

Med Sci Monit 1999; 5(3): CR519-523

ID: 504917


In order to identify' immunologic parameters of prognostic value, we studied changes in immune responses during first cycle of treatment with hrec TNF alpha. The study consisted of 21 patients with locally advanced or metastasis solid tumor (M/F: 12/9 median age, mean 57 years. 38-65) for whom standard therapy was available. Clinical responses were assessed by physical examination, serum markers, computerized tomographic scans of the chest and abdomen, chest X-ray and bone scans every 4 to 8 weeks. The toxicity of TNF was mild in all patients.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree